Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • LDLR
    (1)
  • LPL Receptor
    (1)
  • NF-κB
    (1)
  • Serine Protease
    (1)
  • TLR
    (1)
  • Others
    (2)
TargetMol | Tags By Application
  • ELISA
    (2)
  • Functional assay
    (2)
  • FACS
    (1)
  • FCM
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
  • Cardiovascular System
    (1)
  • Immune System
    (1)
  • Inflammation
    (1)
  • Metabolism
    (1)
Filter
Search Result
Results for "

atherosclerotic cardiovascular disease

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    1
    TargetMol | All_Pathways
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
Evolocumab
T99201256937-27-5
Evolocumab is an inhibitor of the humanized monoclonal antibody PCSK9. It binds to circulating PCSK9 protein, resulting in inhibition of PCSK9 binding to LDLR. It can be used in studies of hypercholesterolemia and atherosclerotic cardiovascular disease.
  • $228
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Anti-oxLDL Antibody
T9901A-1290
Anti-oxLDL Antibody is a specific monoclonal antibody targeting oxidized low-density lipoprotein (oxLDL). As oxLDL is a key pro-inflammatory factor promoting atherosclerotic plaque formation and vessel wall inflammation, this antibody is frequently used to study the pathological mechanisms of cardiovascular disease, plaque stability, and the development of diagnostic assays by neutralizing oxLDL or blocking its interaction with macrophage receptors (e.g., CD36).
    Inquiry